Skip to main content
Cardioxyl Pharmaceuticals logo
  • Company
  • Technology
  • Product Pipeline
  • Clinical Trials
  • Investors
  • News & Events
  • Contacts

Clinical Advisory Board

Wilson S. Colucci, M.D., F.A.C.C., F.A.H.A.-Chairman
Read More


William T. Abraham, M.D., F.A.C.P., F.A.C.C.
Read More


Michael Givertz, M.D.
Read More


David Kass, M.D.
Read More


Marvin Konstam, M.D.
Read More


Doug Mann, M.D.
Read More


Hani Sabbah, Ph.D., FACC, FCCP, FAHA
Read More


Ralph Snyderman, M.D.
Read More


James Young M.D.
Read More


Nitroxyl Technology

Cardioxyl has developed proprietary expertise in the biology, physiology and chemistry of nitroxyl donors

View More

Our Mission

Cardioxyl's mission is to realize the potential of nitroxyl technology through the development of novel therapies that improve the health and quality of life of patients with serious cardiovascular disease.

  • History of Cardioxyl
  • Management Team
  • Board of Directors
  • Clinical Advisory Board
    • Wilson S. Colucci, M.D., F.A.C.C., F.A.H.A.-Chairman
    • William T. Abraham, M.D., F.A.C.P., F.A.C.C.
    • Michael Givertz, M.D.
    • David Kass, M.D.
    • Marvin Konstam, M.D.
    • Doug Mann, M.D.
    • Hani Sabbah, Ph.D., FACC, FCCP, FAHA
    • Ralph Snyderman, M.D.
    • James Young M.D.
  • Scientific Advisory Board
  • Scientific Founders

Privacy Policy Terms of Use Contacts


Exchange East, Suite 212
1450 Raleigh Road,
Chapel Hill, NC 27517
Main: (919) 869-8585

©2012 Cardioxyl Pharmaceuticals, Inc. All rights reserved.